Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colonic Neoplasms 3Colorectal Neoplasms 2Polyps 1Lymphoma, Follicular 1Huntington Disease 1Fatigue 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Fluorouracil 219Leucovorin 202Oxaliplatin 192Irinotecan 150Bevacizumab 110Capecitabine 94Cetuximab 90Folfox protocol 54Chemotherapy, Adjuvant 36Panitumumab 30Colonoscopy 30pembrolizumab 23Drug Therapy 23Nivolumab 22Magnetic Resonance Spectroscopy 22Gemcitabine 21Blood Specimen Collection 20Radiotherapy 19Floxuridine 19Biopsy 19Neoadjuvant Therapy 18Laparoscopy 18IFL protocol 18Early Intervention, Educational 18Celecoxib 18Surveys and Questionnaires 17Surgical Procedures, Operative 16Immunohistochemistry 16Exercise 16trifluridine tipiracil drug combination 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Colonic Neoplasms × eicosapentaenoic acid ethyl ester × Clear all
NCT03428477 2025-04-18

EMT2

University of Leeds

Phase 3 Active not recruiting
418 enrolled
Gastrointestinal

Colonic Neoplasms

NCT04682665 2024-12-04

Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

University of Leeds

Completed
81 enrolled
Gastrointestinal

Colonic Neoplasms

NCT03661047 2021-11-17

OMICC

Massachusetts General Hospital

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Polyps, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡